All Stories

  1. IFN-free combination of sofosbuvir and simeprevir for treatment of genotype 1 hepatitis C infection
  2. Emerging trends in hepatocellular carcinoma incidence and mortality
  3. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
  4. Urinary Biomarkers and Progression of AKI in Patients with Cirrhosis
  5. Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review
  6. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury
  7. Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus–Monoinfected Patients
  8. Advances in interferon-free hepatitis C therapy: 2014 and beyond
  9. Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infection
  10. The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response
  11. Association of AKI With mortality and complications in hospitalized patients with cirrhosis
  12. Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
  13. Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
  14. Management of chronic hepatitis C infection in children
  15. Developing a Modified Directly Observed Therapy Intervention for Hepatitis C Treatment in a Methadone Maintenance Program: Implications for Program Replication
  16. A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
  17. Impact of Insulin-Sensitizing Agents on Risk for Liver Cancer and Liver-Related Death in Diabetic Patients with Compensated Hepatitis C Cirrhosis
  18. Risk of Heart Failure With Human Immunodeficiency Virus in the Absence of Prior Diagnosis of Coronary Heart Disease
  19. The Role of Hepatic Steatosis in Chronic Hepatitis B Infection
  20. Management: Cirrhotic Portal Hypertension
  21. Antibiotic Prophylaxis and Management of Bacterial Infections
  22. A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide Plus Peginterferon and Ribavirin in Naïve Patients With Chronic Hepatitis C Genotype 1 Infection: Final Report
  23. Histologic Disease in Patients with Chronic Hepatitis B, High HBV DNA, and Normal Alanine Aminotransferase Levels
  24. Erratum: Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program
  25. Narrow-band imaging without high magnification to differentiate polyps during real-time colonoscopy: improvement with experience
  26. Liver Disease From Asymptomatic Constrictive Pericarditis
  27. Vasoconstrictor Therapy for the Hepatorenal Syndrome
  28. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: Is there still a role for hepatic venous pressure gradient measurement?
  29. The Impact of Chronic Hepatitis C and Comorbid Psychiatric Illnesses on Health-related Quality of Life
  30. Endoscopic removal of two leaking alkaline batteries
  31. Keratins as Susceptibility Genes for End-Stage Liver Disease
  32. Improving the effectiveness of journal reading in gastroenterology
  33. Graduate Medical Education Research in the 21st Century and JAMA On Call
  34. Endoscopic Approach to the Treatment of Gastrointestinal Bleeding
  35. Use of endoclips in the treatment of massive colonic diverticular bleeding
  36. Liver transplantation for alcoholic liver disease: Current concepts and length of sobriety
  37. Squaric acid immunotherapy for warts in children